skip to Global Navigation Bar skip to main content

homeHome > About Us > Recruitment > News


News Content
Daewoong Pharmaceutical’s botulinum toxin about to be released in Europe with European CHMP’s recommendation for approval
Date 2019-04-26 Hit 2075
News List
Prev Daewoong Pharmaceutical announced the excellence of Nabota through an overseas specialist training program.
Next Daewoong Pharmaceutical has released ‘Olomax’ for both hypertension and hyperlipidemia